ROYAL BANK OF CANADA - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$222,000
+54.2%
10,813
+49.5%
0.00%
Q2 2023$144,000
-92.0%
7,234
-93.1%
0.00%
Q1 2023$1,795,000
+784.2%
104,765
+909.0%
0.00%
Q4 2022$203,000
+2155.6%
10,383
+1848.0%
0.00%
Q3 2022$9,000
-96.5%
533
-97.2%
0.00%
Q2 2022$259,000
+547.5%
18,829
+643.3%
0.00%
Q1 2022$40,000
-79.5%
2,533
-71.7%
0.00%
Q4 2021$195,000
+91.2%
8,941
+162.3%
0.00%
Q3 2021$102,000
-15.0%
3,409
+25.3%
0.00%
Q2 2021$120,000
-92.5%
2,720
-92.4%
0.00%
Q1 2021$1,592,000
+19800.0%
35,886
+26286.8%
0.00%
Q4 2020$8,000
+300.0%
136
-9.3%
0.00%
Q1 2020$2,000
-92.3%
150
-86.7%
0.00%
Q4 2019$26,000
+62.5%
1,124
+77.0%
0.00%
Q3 2018$16,000
-52.9%
635
-63.5%
0.00%
Q2 2018$34,000
-24.4%
1,741
-27.3%
0.00%
Q1 2018$45,0002,3940.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders